What You Should Know:
– Paige, a provider of AI-powered pathology solutions, today announced a significant expansion of Paige PanCancer Detect, its groundbreaking cancer detection tool.
– Originally launched in 2024 with the ability to identify…
Continue Reading
What You Should Know:
– Color Health, a provider of precision health solutions released its second annual Employer Insights Report, revealing a disconnect between employer priorities and the reality of cancer care benefits offered to…
Continue Reading
The confluence of new technologies with artificial intelligence (AI) and machine learning (ML) analytical techniques is rapidly advancing the field of precision oncology, promising to improve diagnostic approaches and therapeutic strategies for patients with…
Continue Reading
What You Should Know:
– Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.
– The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare,…
Continue Reading
What You Should Know:
– C the Signs, a developer of AI-powered cancer detection solutions, today announced an $8 million funding round led by Khosla Ventures.
– The investment will fuel the company’s expansion from the…
Continue Reading
What You Should Know:
– Quibim, a leading healthtech company pioneering the use of imaging biomarkers for precision medicine, announced today the close of its $50 million Series A financing.
– The company has experienced remarkable growth in…
Continue Reading
Revolutionary Healthcare Partnership Announced
GE HealthCare Technologies Inc. and the University of California San Francisco’s Department of Radiology and Biomedical Imaging have joined forces in a landmark partnership focusing on advanced imaging and precision oncology…
Groundbreaking AI Study Transforms Cancer Diagnostics
Lunit, in partnership with Japan’s National Cancer Center Hospital East (NCCHE), has published breakthrough research in the Journal of Clinical Oncology Precision Oncology. Their study demonstrates how AI-powered pathology…
DeepScribe, an AI-enabled clinical documentation tool for healthcare providers, is partnering with oncology-focused digital health company Flatiron Health to bring DeepScribe’s AI documentation to clinicians that use Flatiron’s OncoEMR, cloud-based electronic medical record platform.According…
Continue Reading
What You Should Know:
– DeepScribe, the ambient AI of choice for specialty care, and Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology, today announced a…
Continue Reading
